GCM
CL icon

Genus Capital Management’s Colgate-Palmolive CL Stock Holding History

Genus Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.91M Buy
97,163
+37,838
+64% +$3.31M 0.88% 36
2026
Q1 		$5.06M Buy
+59,325
New +$5.29M 0.58% 60
2024
Q2 		– Sell
-38,620
Closed -$3.56M – 230
2024
Q1 		$3.48M Buy
+38,620
New +$3.27M 0.45% 77
2023
Q4 		– Sell
-37,990
Closed -$2.86M – 230
2023
Q3 		$2.7M Sell
37,990
-14,700
-28% -$1.1M 0.43% 76
2023
Q2 		$4.06M Buy
+52,690
New +$4.08M 0.6% 54

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Genus Capital Management's CL Position: Q2 2026 in Review

Genus Capital Management increased its Colgate-Palmolive (CL) stake by 64% in Q2 2026, buying an estimated $3.31M and bringing the position to 97,163 shares worth $8.91M. The position accounts for 0.88% of the portfolio, ranked #36.

Genus Capital Management first reported a position in CL in Q2 2023 and has held it in 5 quarters since. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Genus Capital Management held 97,163 shares of Colgate-Palmolive worth $8.91M as of Q2 2026.
  • Genus Capital Management bought 37,838 Colgate-Palmolive shares in Q2 2026, an estimated $3.31M.
  • Colgate-Palmolive made up 0.88% of Genus Capital Management's portfolio in Q2 2026, its #36 holding.
  • Genus Capital Management first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 5 quarters since.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.